Ocedurenone

DB21519InvestigationalSmall molecule

Ocedurenone is a small molecule drug. The usage of the INN stem '-renone' in the name indicates that Ocedurenone is a mineralocorticoid receptor (MR, MCR, aldosterone receptor) antagonist. Ocedurenone is... Ocedurenone is under investigation in clinical trial NCT04968184 (Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)).

Chemical structure of Ocedurenone
Formula / weight
C28H30ClN5O2 · 504.03 g/mol (avg)
Code names
KBP-5074

Resolves to

Compound
UNIIL46509378RCAS1359969-24-6ChEMBLCHEMBL5314961ChEBI759652PubChem75593324
Structure
InChIKeyUXHQLGLGLZKHTC-CUNXSJBXSA-NSMILES[H][C@]12CCC3=NC(=CC=C3C1=NN([C@H]2C1CCCC1)C1=CC(Cl)=C(C=C1)C#N)C(=O)N1CCC(O)CC1
Targets
P08235NR3C2

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Ocedurenone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In